Author

A. Winters

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Ecology· 1 Evolutionary Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:drug response / drug discovery· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:ecology & biodiversity· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. E. Gillen· 2 shared A. Krug· 2 shared B. M. Stevens· 2 shared C. T. Jordan· 2 shared D. A. Pollyea· 2 shared H. Tolison· 2 shared K. Engel· 2 shared M. L. Amaya· 2 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. E. Gillen

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium

A. I. Sheth, K. Engel, H. Tolison, M. J. Althoff, M. L. Amaya, A. Krug, T. Young, S. Pei, S. B. Patel, M. Minhajuddin, A. Winters, R. Miller, I. Shelton, J. St-Germain, T. Ling, , C. T. Jordan

This study identifies mitochondrial calcium utilization as a metabolic requirement of venetoclax-resistant acute myeloid leukemia stem cells and shows that targeting mitochondrial calcium uptake can eradicate these cells.

bioRxiv · Oct 2, 2023Cancer Biology

A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy

S. Pei, A. E. Gillen, I. T. Shelton, B. M. Stevens, M. Gasparetto, K. Engel, S. Staggs, Y. Wang, W. Showers, A. Inguva, M. L. Amaya, M. Minhajuddin, A. Winters, S. B. Patel, H. Tolison, , C. T. Jordan

The paper identifies a new type of monocytic leukemia stem cell (m-LSC) in AML patients treated with venetoclax, showing its distinct characteristics and clinical relevance.

Cancer Discovery · Sep 6, 2023Peer-reviewedCancer Biology

Not just the sum of its parts: geographic variation and non-additive effects of pyrazines in the chemical defence of an aposematic moth

C. Ottocento, A. Winters, B. Rojas, J. Mappes, E. Burdfield-Steel

The paper investigates geographic variation and non-additive effects of pyrazines in the chemical defence of the wood tiger moth, finding that SBMP and IBMP have complex interactions and efficacy depending on concentration and predator context.

bioRxiv · May 28, 2022Evolutionary Biology

Isolation and characterisation of quercitrin as a potent anti-sickle cell anaemia agent from Alchornea cordifolia.

O. Adeniyi, R. Baptista, S. Bhowmick, A. R. Cookson, R. Nash, A. Winters, L. Mur

This study isolates and characterizes quercitrin from Alchornea cordifolia as a potent anti-sickling agent, showing significant inhibition of HbSS erythrocyte sickling and metabolic changes associated with sickle cell anaemia.

bioRxiv · Nov 11, 2021Pharmacology & Toxicology

Subtle, seasonal and potentially important: Are phytotoxic foliage leachates overlooked in plant invasion studies?

G. Jones, M. Tomlinson, R. Owen, J. Scullion, A. Winters, T. Jenkins, J. Ratcliffe, D. Gwynn-Jones

This study investigates seasonal variation in phytotoxic compounds from Rhododendron ponticum leaves and their impact on seed germination.

bioRxiv · Mar 5, 2019 · PreprintEcology